Safe Age for Over-the-Counter Cold Medications in Children

Age-Based Recommendations

The American Academy of Pediatrics and FDA recommend that children under 4 years of age should not use over-the-counter (OTC) cold medications due to potential toxicity and lack of proven efficacy 1, 2, 3
Children 4-6 years: OTC cold medications should generally be avoided, as the FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended against their use in children under 6 years 1, 4
Children 6 years and older: May use OTC cold medications according to package directions, but benefits remain limited 1

Between 1969 and 2006, there were 54 fatalities associated with decongestants and 69 fatalities associated with antihistamines in children under 6 years 1, 5
Common causes of adverse events include use of multiple cold/cough products containing the same ingredients 1
Intentional overdose is a cause of adverse events in children 1
In 2007, major manufacturers voluntarily removed cough and cold medications for children under 2 years from the OTC market 1
In 2018, the FDA altered labeling for prescription opioid cough and cold medicines to limit their use to adults ≥18 years 2

Controlled trials have shown that antihistamine-decongestant combination products are not effective for symptoms of upper respiratory tract infections in young children 1
OTC cough medications have little, if any, benefit in the symptomatic control of acute cough in children 2

For children with acute cough, honey may offer more relief for cough symptoms than no treatment, diphenhydramine, or placebo (only for children 1 year and older due to botulism risk) 2

Systematic reviews have concluded that there is no evidence to support using β2-agonists (including salbutamol) in children with acute cough and no evidence of airflow obstruction 6
The American College of Chest Physicians guidelines explicitly state that "there is no evidence to support using β2-agonists in children with acute cough and no evidence of airflow obstruction" 6, 7
Studies on inhaled salbutamol for chronic cough have shown no benefit 6

OTC cough medications have been associated with significant morbidity and even mortality in young children 6
OTC drugs are common unintentional ingestion medications in children under 5 years of age 6
In 2018, the FDA altered labeling for prescription opioid cough medicines to limit their use to adults ≥18 years 7

For children with acute cough over 1 year of age, honey may offer more relief for cough symptoms than no treatment, diphenhydramine, or placebo 7
For chronic cough (>4 weeks) with asthma features, a 2-4 week trial of inhaled corticosteroids may be considered 6

For acute cough in children under 4 years, avoid all cough medications including salbutamol 6, 7
For chronic cough in children under 4 years, if asthma is suspected based on clinical features, consider appropriate asthma therapy under specialist guidance 6, 7
Do not use salbutamol syrup for non-specific cough 6

Assuming that cough always represents asthma and treating with bronchodilators without evidence of airflow obstruction 6, 7
Using medications with potential for harm despite lack of evidence for efficacy 6

Between 1969-2006, there were 54 deaths associated with decongestants and 69 deaths associated with antihistamines in children under 6 years, with 43 decongestant deaths occurring in infants under 1 year, highlighting the potential toxicity of these medications in young children 8
Controlled trials demonstrate that antihistamine-decongestant combinations are ineffective for upper respiratory tract infection symptoms in young children, emphasizing the need for alternative treatments 8
Second-generation antihistamines (such as cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine) are preferable to first-generation agents due to better safety profiles with minimal cognitive and antimuscarinic side effects in children 6 years and older 8

Medication errors from incorrect dosing are common, particularly in young children, and can lead to unintentional overdose and adverse events 8
Decongestants, specifically topical vasoconstrictors, should be used with extreme care below age 1 year due to narrow therapeutic window and risk of cardiovascular and CNS side effects 8